EURURO Vol. 73 No. 1

Previous Page

Next Page

Page Background

e u r o p e a n u r o l o g y , vo l . 7 3 , n o . 1 , J a nu a ry 2 0 1 8

Words ofWisdom

139

Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient-specific Molds to Correlate Images with Whole-mount Pathology

T. van der Kwast

140

Re: Impact of Radical Prostatectomy on Long-term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration

D.W. Good, A.S. McNeill

140

Re: Salvage High-intensity Focused Ultrasound (HIFU) for Locally Recurrent Prostate Cancer After Failed Radiation Therapy: Multi-institutional Analysis of 418 Patients

G. Ploussard

141

Re: Metastasis-free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

M. Spahn

142

Re: Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer

V. Pansadoro, A. Brassetti

143

Re: Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer

N. Ibragimova, Z. Zhanzak, A. Meyerbekova, Y. Xie

145

[ 18 F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis

E. Accorsi Buttini, F. Maritati, A. Vaglio

147

Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!

C. Messina, M. Messina, F. Boccardo

e9

Re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 http://dx.doi.org/10.1016/j.eururo.2017.07.032

U. De Giorgi, V. Conteduca, E. Scarpi

e11

Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi’s Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 http://dx.doi.org/10.1016/j.eururo.2017.07.034

M. Del Re, E. Biasco, S. Crucitta, L. Derosa, E. Rofi, C. Orlandini, M. Miccoli, L. Galli, A. Falcone,

G.W. Jenster, R.H. van Schaik, R. Danesi

e13

Re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402–7 http://dx.doi.org/10.1016/j.eururo.2017.07.033

B. Lee, J.H. Kim

e15

Reply to Bora Lee and Jae Heon Kim’s Letter to the Editor re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402–7 http://dx.doi.org/10.1016/j.eururo.2017.07.037

A.D. Uren, N. Cotterill, C. Harding, C. Hillary, C. Chapple, M. Klaver, D. Bongaerts, Z. Hakimi,

P. Abrams

e17

Congress Calendar

Research Letters

Letters to the Editor

published online